255 related articles for article (PubMed ID: 16822421)
21. Prevalence and imaging of hepatic involvement in malignant lymphoproliferative disease.
Bach AG; Behrmann C; Holzhausen HJ; Spielmann RP; Surov A
Clin Imaging; 2012; 36(5):539-46. PubMed ID: 22920359
[TBL] [Abstract][Full Text] [Related]
22. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
Abel GA; Bertrand KA; Earle CC; Laden F
Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
[TBL] [Abstract][Full Text] [Related]
23. Germline copy number variation associated with Mendelian inheritance of CLL in two families.
Brown JR; Hanna M; Tesar B; Pochet N; Vartanov A; Fernandes SM; Werner L; Ash M; Roden CA; MacConaill L; Hainz U; Longtine J; Wang YE; Correll M; Van de Peer Y; Regev A; Wu C; Neuberg D; Freedman AS
Leukemia; 2012 Jul; 26(7):1710-3. PubMed ID: 22382893
[No Abstract] [Full Text] [Related]
24. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
25. Socio-economic class distribution of the prognostic variants of lymphoproliferative cancers in Nigerians.
Okpala IE; Okpala JU
Afr J Med Med Sci; 1992 Oct; 21(1):79-83. PubMed ID: 1288248
[TBL] [Abstract][Full Text] [Related]
26. High incidence of stomach cancer in relatives of patients with malignant lymphoproliferative disorders.
Gencík A; Buser M; Temminck B; Obrecht JP; Weber W; Müller H
Cancer Detect Prev Suppl; 1987; 1():121-5. PubMed ID: 3155377
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Soubeyran P; Marit G; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1147-60. PubMed ID: 18781390
[TBL] [Abstract][Full Text] [Related]
28. [Chronic lymphoproliferative syndromes in Chile. A prospective study in 132 patients].
Cabrera ME; Marinov N; Guerra C; Morilla R; Matutes E
Rev Med Chil; 2003 Mar; 131(3):291-8. PubMed ID: 12790078
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
[TBL] [Abstract][Full Text] [Related]
30. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
[TBL] [Abstract][Full Text] [Related]
31. A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.
Pratt G; Fenton JA; Allsup D; Fegan C; Morgan GJ; Jackson G; Sunter NJ; Hall AG; Irving JA; Allan JM
Br J Haematol; 2010 Aug; 150(3):371-3. PubMed ID: 20408839
[No Abstract] [Full Text] [Related]
32. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
[TBL] [Abstract][Full Text] [Related]
33. The changing incidence of lymphoproliferative disorders in Yorkshire.
Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R
Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676
[TBL] [Abstract][Full Text] [Related]
34. [Changes in Ca, Mg-dependent endonuclease of DNA in isolated nuclei of human lymphocytes in lymphoproliferative diseases].
Tkacheva TI; Kirzon SS; Khodarev NN; Botrin II
Biull Eksp Biol Med; 1990 Jun; 109(6):543-6. PubMed ID: 2397289
[TBL] [Abstract][Full Text] [Related]
35. Number of siblings and risk of hodgkin's and other lymphoid neoplasms.
Chatenoud L; Gallus S; Altieri A; Negri E; Talamini R; Franceschi S; La Vecchia C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):552. PubMed ID: 15734990
[No Abstract] [Full Text] [Related]
36. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
[TBL] [Abstract][Full Text] [Related]
37. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation and risk of chronic lymphocytic leukaemia.
Crowther-Swanepoel D; Houlston RS
Semin Cancer Biol; 2010 Dec; 20(6):363-9. PubMed ID: 20833250
[TBL] [Abstract][Full Text] [Related]
39. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
[TBL] [Abstract][Full Text] [Related]
40. Familial risks and temporal incidence trends of multiple myeloma.
Altieri A; Chen B; Bermejo JL; Castro F; Hemminki K
Eur J Cancer; 2006 Jul; 42(11):1661-70. PubMed ID: 16753294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
